PURPOSE: To study whether flap thickness influences laser in situ keratomileusis (LASIK) results. METHODS: This comparative, non-randomized, retrospective study comprised 421 LASIK eyes (233 patients) with spherical equivalent refraction between -0.60 and -6.00 diopters (D). Laser in situ keratomileusis was performed with the Moria One manual microkeratome and the Chiron Technolas 217C laser. Depending on the flap thickness, the eyes were divided into three groups (group 1, flap thickness < or =100 microm; group 2, flap thickness > 100 microm and < 130 microm; and group 3, flap thickness > or = 130 pm). For each group uncorrected visual acuity (UCVA), best spectacle-corrected visual acuity, residual spherical equivalent refraction, and keratometric power (D) were measured 1 day, 1 week, 1 month, and 6 months after LASIK. Complications, retreatment, and correlation between flap thickness and preoperative corneal thickness and keratometric power were also analyzed. RESULTS: One month postoperatively, UCVA was > or = 20/20 in 76% (96 eyes), 56% (79 eyes), and 61% (93 eyes) of eyes in the three group, respectively (P = .015). One month postoperatively, UCVA was > or = 20/25 in 88% (111 eyes), 76% (108 eyes), and 76% (116 eyes) of eyes in the three groups, respectively (P = .015). Complication rate and retreatment rate were not statistically different among the groups. At 6-month follow-up, no statistically significant differences were noted in UCVA between the groups. Significant correlations between flap thickness and preoperative corneal thickness (P < .0001) and between flap thickness and preoperative keratometric power (P < .05) were found. CONCLUSION: Patients with flaps < or = 100 pm had better functional results at 1 month than those with thicker flaps. It may be important to perform LASIK with thin flaps to save corneal tissue in the stromal bed.
PURPOSE: To study whether flap thickness influences laser in situ keratomileusis (LASIK) results. METHODS: This comparative, non-randomized, retrospective study comprised 421 LASIK eyes (233 patients) with spherical equivalent refraction between -0.60 and -6.00 diopters (D). Laser in situ keratomileusis was performed with the Moria One manual microkeratome and the Chiron Technolas 217C laser. Depending on the flap thickness, the eyes were divided into three groups (group 1, flap thickness < or =100 microm; group 2, flap thickness > 100 microm and < 130 microm; and group 3, flap thickness > or = 130 pm). For each group uncorrected visual acuity (UCVA), best spectacle-corrected visual acuity, residual spherical equivalent refraction, and keratometric power (D) were measured 1 day, 1 week, 1 month, and 6 months after LASIK. Complications, retreatment, and correlation between flap thickness and preoperative corneal thickness and keratometric power were also analyzed. RESULTS: One month postoperatively, UCVA was > or = 20/20 in 76% (96 eyes), 56% (79 eyes), and 61% (93 eyes) of eyes in the three group, respectively (P = .015). One month postoperatively, UCVA was > or = 20/25 in 88% (111 eyes), 76% (108 eyes), and 76% (116 eyes) of eyes in the three groups, respectively (P = .015). Complication rate and retreatment rate were not statistically different among the groups. At 6-month follow-up, no statistically significant differences were noted in UCVA between the groups. Significant correlations between flap thickness and preoperative corneal thickness (P < .0001) and between flap thickness and preoperative keratometric power (P < .05) were found. CONCLUSION: Patients with flaps < or = 100 pm had better functional results at 1 month than those with thicker flaps. It may be important to perform LASIK with thin flaps to save corneal tissue in the stromal bed.
Authors: Dimitri T Azar; Ramon C Ghanem; Jose de la Cruz; Joelle A Hallak; Takashi Kojima; Faisal M Al-Tobaigy; Sandeep Jain Journal: J Cataract Refract Surg Date: 2008-12 Impact factor: 3.351
Authors: Mohammad Reza Djodeyre; Jaime Beltran; Julio Ortega-Usobiaga; Felix Gonzalez-Lopez; Ana Isabel Ruiz-Rizaldos; Julio Baviera Journal: Clin Ophthalmol Date: 2016-03-29